Chemical formula: C₂₁H₃₆O₅ Molecular mass: 489.65 g/mol PubChem compound: 45266502
Carboprost is indicated for:
Population group: women, only adults (18 - 65 years old)
Treatment of post-partum haemorrhage due to uterine atony and refractory to conventional methods of treatment with oxytocic agents and ergometrine used either alone or in combination.
Conventional therapy should usually consist of 0.5-1 mg ergometrine with up to 50 units of oxytocin infused intravenously over periods of time from 20 minutes to 12 hours. The dosage and duration of administration should reflect the seriousness of the clinical situation.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Carboprost is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
